YHO-13351 is primarily utilized in research and development within the pharmaceutical and biotechnology sectors. It is often investigated for its potential role in modulating specific biological pathways, particularly in the context of cancer therapy. Researchers study its effects on cellular mechanisms to evaluate its efficacy in inhibiting tumor growth or enhancing the effectiveness of existing treatments. Additionally, YHO-13351 is explored for its possible applications in targeted drug delivery systems, aiming to improve precision and reduce side effects in therapeutic interventions. Its properties make it a candidate for further exploration in preclinical studies to assess its safety, pharmacokinetics, and pharmacodynamics.